Trinitas Capital focuses primarily on investing in the healthcare industry, along with IT services, semiconductors, cybersecurity, and TMT sectors. The firm has a preference for startups that have been operating for 4-5 years and typically invests in rounds with 9 participants. Some of the successful portfolio startups of Trinitas Capital include Vividion Therapeutics, Gritstone Oncology, and Quanterix. The fund has a higher rate of exits compared to other organizations and tends to invest in deals ranging from $50 million to $100 million. While Trinitas Capital is based in China, it predominantly invests in companies in the United States.